Effects of local intracoronary paclitaxel delivery using the Remedy transport catheter on neointimal hyperplasia after stent implantation in a porcine model

Cardiovascular Revascularization Medicine

Volumn 12, Issue 2, 2011, Pages 82-89

  Milewski, Krzysztof ^a,b,c   Zurakowski, Aleksander ^a   Pajak, Jacek ^a   Liszka, Lukasz ^a   Debinski, Marcin ^a   Buszman, Piotr P ^b,c   Samra, Motaz Abu ^a   Dominek, Piotr ^d   Aboodi, Michael S ^e   Kaluza, Grzegorz L ^e   Buszman, Pawel ^a,b,c  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b American Heart of Poland   (Poland)

^c University of Bristol ^*  (Poland)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

Paclitaxel; Porcine; Stent; Transport catheter

Indexed keywords

PACLITAXEL; POLTAXEL; UNCLASSIFIED DRUG;

ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BARE METAL STENT; CATHETER; CORONARY STENT; DOMESTIC PIG; DRUG DOSE COMPARISON; DRUG ELUTING STENT; FOLLOW UP; HISTOPATHOLOGY; INTRACORONARY INFUSION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CARDIAC CATHETERS; CARDIOVASCULAR AGENTS; CELL PROLIFERATION; CORONARY ANGIOGRAPHY; CORONARY VESSELS; DRUG-ELUTING STENTS; HYPERPLASIA; MODELS, ANIMAL; NEOINTIMA; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; SUS SCROFA; TIME FACTORS;

EID: 79952725705     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2010.05.002     Document Type: Article

References (35)

1. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 2007, 27:1500-1510.
2. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006, 48:193-202.
3. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, Skorija K, Weber DK, Gold HK, Virmani R Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005, 112:270-278.
4. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006, 47:175-181.
5. Virmani R, Farb A, Guagliumi G, Kolodgie FD Drug-eluting stents: caution and concerns for long-term outcome. Coron Artery Dis 2004, 15:313-318.
6. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?. Circulation 2004, 109:701-705.
7. Chen MC, Liang HF, Chiu YL, Chang Y, Wei HJ, Sung HW A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus. J Control Release 2005, 108:178-189.
8. Krucoff MW, Kereiakes DJ, Petersen JL, Mehran R, Hasselblad V, Lansky AJ, Fitzgerald PJ, Garg J, Turco MA, Simonton CA, Verheye S, Dubois CL, Gammon R, Batchelor WB, O'Shaughnessy CD, Hermiller JB, Schofer J, Buchbinder M, Wijns W A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study. J Am Coll Cardiol 2008, 51:1543-1552.
9. Reno F, Traina V, Cannas M Cellular behavior of neointima-like cells onto vitamin E-enriched poly(d,l)lactic acid. Biomol Eng 2007, 24:307-312.
10. Tsujino I, Ako J, Honda Y, Fitzgerald PJ Drug delivery via nano-, micro and macroporous coronary stent surfaces. Expert Opin Drug Deliv 2007, 4:287-295.
11. Hong MK, Wong SC, Farb A, Mehlman MD, Virmani R, Barry JJ, Leon MB Feasibility and drug delivery efficiency of a new balloon angioplasty catheter capable of performing simultaneous local drug delivery. Coron Artery Dis 1993, 4:1023-1027.
12. Hong MK, Wong SC, Farb A, Mehlman MD, Virmani R, Barry JJ, Leon MB Localized drug delivery in atherosclerotic arteries via a new balloon angioplasty catheter with intramural channels for simultaneous local drug delivery. Cathet Cardiovasc Diagn 1995, 34:263-270. [discussion 71].
13. Kalinowski M, Alfke H, Hamann C, Viehofer K, Klose KJ, Barry JJ, Wagner HJ Effects of altering infusion parameters on intimal hyperplasia following local catheter-based delivery into the rabbit iliac artery. Atherosclerosis 2004, 172:71-78.
14. Kiesz RS, Buszman P, Martin JL, Deutsch E, Rozek MM, Gaszewska E, Rewicki M, Seweryniak P, Kosmider M, Tendera M Local delivery of enoxaparin to decrease restenosis after stenting: results of initial multicenter trial: Polish-American Local Lovenox NIR Assessment study (The POLONIA study). Circulation 2001, 103:26-31.
15. Kalinowski M, Alfke H, Bergen S, Klose KJ, Barry JJ, Wagner HJ Comparative trial of local pharmacotherapy with l-arginine, r-hirudin, and molsidomine to reduce restenosis after balloon angioplasty of stenotic rabbit iliac arteries. Radiology 2001, 219:716-723.
16. Buszman P, Zurakowski A, Gruszka A, Szkrobka I, Peszek-Przybyla E, Radwan K, Milewski K, Barteczko Z, Tendera M Local paclitaxel delivery as a treatment of persistent, recurrent in-stent restenosis - safety assessment. Kardiol Pol 2006, 64:268-272. [discussion 73-4].
17. Maillard L, Van Belle E, Tio FO, Rivard A, Kearney M, Branellec D, Steg PG, Isner JM, Walsh K Effect of percutaneous adenovirus-mediated Gax gene delivery to the arterial wall in double-injured atheromatous stented rabbit iliac arteries. Gene Ther 2000, 7:1353-1361.
18. Tian W, Kuhlmann MT, Pelisek J, Scobioala S, Quang TH, Hasib L, Klocke R, Jahn UR, Nikol S Paclitaxel delivered to adventitia attenuates neointima formation without compromising re-endothelialization after angioplasty in a porcine restenosis model. J Endovasc Ther 2006, 13:616-629.
19. Buszman P, Trznadel S, Milewski K, Rzezniczak J, Przewlocki T, Kosmider M, Wojcik J, Janczak J, Zurakowski A, Kondys M, Krol M, Kinasz L, Jaklik A, Rzeszutko L, Kaluza GL, Kiesz S, Gil R Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: a prospective multicenter registry. Catheter Cardiovasc Interv 2008, 71:51-57.
20. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vliestra RE, Holmes DR Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. Circulation 1990, 82:2190-2200.
21. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998, 31:224-230.
22. Speck U, Scheller B, Abramjuk C, Breitwieser C, Dobberstein J, Boehm M, Hamm B Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology 2006, 240:411-418.
23. Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 2004, 110:810-814.
24. Herdeg C, Gohring-Frischholz K, Haase KK, Geisler T, Zurn C, Hartmann U, Wohrle J, Nusser T, Dippon J, May AE, Gawaz M Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation. Circ Cardiovasc Interv 2009, 2:294-301.
25. Axel DI, Kunert W, Goggelmann C, Oberhoff M, Herdeg C, Kuttner A, Wild DH, Brehm BR, Riessen R, Koveker G, Karsch KR Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997, 96:636-645.
26. Herdeg C, Oberhoff M, Siegel-Axel DI, Baumbach A, Blattner A, Kuttner A, Schroder S, Karsch KR Paclitaxel: a chemotherapeutic agent for prevention of restenosis? Experimental studies in vitro and in vivo. Z Kardiol 2000, 89:390-397.
27. Oberhoff M, Herdeg C, Al Ghobainy R, Cetin S, Kuttner A, Horch B, Baumbach A, Karsch KR Local delivery of paclitaxel using the double-balloon perfusion catheter before stenting in the porcine coronary artery. Catheter Cardiovasc Interv 2001, 53:562-568.
28. Aragon J, Kar S, Tio F, Trauthen B, Parisky A, Watanabe C, Jamali A, Eigler N, Serruys PW, Litvack F The effect of variable release kinetics on paclitaxel efficacy from a drug eluting stent in a porcine model. EuroIntervention 2005, 1:228-235.
29. Jabara R, Chronos N, Tondato F, Conway D, Molema W, Park K, Mabin T, King S, Robinson K Toxic vessel reaction to an absorbable polymer-based paclitaxel-eluting stent in pig coronary arteries. J Invasive Cardiol 2006, 18:383-390.
30. Dommke C, Haase KK, Suselbeck T, Streitner I, Haghi D, Metz J, Borggrefe M, Herdeg C Local paclitaxel delivery after coronary stenting in an experimental animal model. Thromb Haemost 2007, 98:674-680.
31. Scheller B, Speck U, Romeike B, Schmitt A, Sovak M, Bohm M, Stoll HP Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. Eur Heart J 2003, 24:1462-1467.
32. Cremers B, Biedermann M, Mahnkopf D, Bohm M, Scheller B Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model. Clin Res Cardiol 2009, 98:325-330.
33. Fanggiday JC, Stella PR, Guyomi SH, Doevendans PA Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry. Catheter Cardiovasc Interv 2008, 71:629-635.
34. Cortese B. Paclitaxel-eluting balloon versus paclitaxel-eluting stent in small coronary vessel disease. The Piccoleto trial. Presented at: EuroPCR; May 21, 2009; Barcelona, Spain.
35. Milewski K, Buszman P, Zurakowski A, Pajak J, Stojko J, AbuSamra M Biodegradable polymer coated paclitaxel eluting stents in the porcine coronary arteries (abstract). Am J Cardiol 2005, 96(suppl 7A).